Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 822 results for "drl"

Dr. Reddy's acquires nicotine therapy patch Habitrol
India TV

DRL closes acquisition of Habitrol brand from Novartis

Dr Reddy's Laboratories (DRL) has closed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health following issuance of the proposed consent order from the US Federal Trade ... Financial Express, 12 hours ago
Dr. Reddys acquires nicotine therapy patch Habitrol Bombay News.Net, 12 hours ago

23 images for drl

India TV, 11 hours ago, 2 weeks ago
Car Showroom, 1 week ago
Manufacturing News Web, 2 weeks ago
International Business Times India, 2 weeks ago
International Business Times India, 2 weeks ago, 2 weeks ago
Zigwheels, 2 weeks ago
GPI News, 2 weeks ago, 2 weeks ago

Dr. Reddy's launches anti-viral drug in U.S.

Comment · print · T T T+· T- TOPICS Indian pharmaceutical major, Dr. Reddy's Laboratories (DRL) said on Monday, it had launched Valganciclovir tablets, an anti-viral drug in the U.S. market after receiving U.S. Food and Drug ...
 The Hindu3 days ago Dr Reddy Laboratories : DRL LAUNCHES DOCETAXEL INJECTION IN US MARKET  4 Traders2 weeks ago Dr Reddy Laboratories : NEW ANTI-CANCER INJECTION FROM DRL  4 Traders3 weeks ago DRL launches Docetaxel  The Echo Of India3 weeks ago

DRL launches generic anti-viral tablets in US

Drugmaker Dr Reddy's has launched the generic version of Valcyte, a drug used as an antiviral post organ transplant in patients infected with HIV. The drug launch comes after another Indian company Ranbaxy's tentative approval for this drug was ...
 Financial Chronicle3 days ago

Approval for more than 60 ANDAs pending: DRL

Over the last few months there have been 5 or 6 audits. Since DRL has invested quite significantly in terms of the cultural transformation in quality area, it got some of the places zero 483 which is uncommon, says CFO Saumen Chakraborty.
 Money Control2 weeks ago

US FDA discovers lapses at DRL's Srikakulam plant

US health regulator Food and Drug Administration (FDA) has procedural deviations at Dr Reddy's Laboratories manufacturing plant at Srikakulam Hyderabad: US health regulator Food and Drug Administration (FDA) has procedural deviations at Dr ...
 Deccan Chronicle3 weeks ago Srikakulam plant gets Form 483 for lapses: DRL  Financial Chronicle3 weeks ago US FDA discovers lapses in DRL’s Srikakulam plant  Asian Age3 weeks ago

DRL Visakhapatnam Plant Gets FDA Fiat on Suspected Lapses

HYDERABAD: Dr Reddy's Laboratories Ltd (DRL) came under the US health regulator Food and Drug Administration (FDA) scanner for procedural deviations at one of its manufacturing plants in Visakhapatnam. It may be noted that the FDA had conducted an ...
 New Indian Express3 weeks ago Government Eyes $340 Billion Exports This Fiscal  INooz3 weeks ago Lubiprostone Patent Row Lands DRL in Court  New Indian Express3 weeks ago

Here's why Sun, Lupin, DRL are still best pharma bets

Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the stock will not look that expensive thereon, says Nitin Agrawal.
 Money Control4 weeks ago Ranbaxy, Sun Pharma fall 4-5%; analysts say DRL to benefit  Money Control1 month ago

Buy Dr Reddys Labs; target of Rs 3750: Angel Broking

Angel Broking`s research report on Dr Reddys Labs For 2QFY2015, Dr Reddy's Laboratories (DRL) posted net sales of Rs3,587.9cr (V/s an expected Rs3,900cr), a yoy growth of 6.9% yoy. The growth was subdued as the US geography which is the company's ...
 Moneycontrol.com1 month ago Accumulate Dr Reddys Labs; target of Rs 3485: KRChoksey  Moneycontrol.com1 month ago Dr Reddy's Laboratories 2QFY2015 performance highlights and results update  Stock Markets Review1 month ago
International Business Times India

Maruti Suzuki SX4 S-Cross Spied with HID Projector Headlamps and DRL

A new batch spy shot of Maruti's SX4 S-Cross has emerged on the cyberspace, giving the best look yet at the new model. Maruti Suzuki SX4 S-Cross Spied With HID Projector Headlamps and DRL The latest set of SX4 S-Cross spy ...
 International Business Times India2 weeks ago (Maruti) Suzuki SX4 S-Cross gets two tone body colour  Rush Lane1 month ago

DRL receives 483 observations for Unit 6 of Vizag plant

The Vizag plant, which manufactures active pharmaceutical ingredient (API) and bulk drugs, was visited by the US Food and Drug Administration last week.
 Money Control3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less